Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,881 | 10,741 | 1 | 0 | 1,027 |
| TOTAL | $9,093 | $10,951 | $1 | $0 | $1,144 |
| Non-Current Assets | |||||
| PPE Net | 270 | 233 | N/A | N/A | 241 |
| Other Non-Current Assets | 130 | 129 | 0 | 0 | 60 |
| TOTAL | $400 | $362 | $N/A | $N/A | $301 |
| Total Assets | $9,492 | $11,312 | $1 | $0 | $1,445 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 836 | 477 | 10 | 18 | 710 |
| Accrued Expenses | 1,419 | 1,271 | N/A | N/A | 879 |
| TOTAL | $2,255 | $1,748 | $10 | $18 | $1,589 |
| Non-Current Liabilities | |||||
| TOTAL | $36 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,290 | $1,748 | $10 | $18 | $1,589 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49 | 48 | 51 | 41 | 41 |
| Common Shares | 7 | 7 | 184 | 169 | 3 |
| Retained earnings | -15,364 | -12,903 | -311 | -301 | -5,847 |
| TOTAL | $7,202 | $9,564 | $-9 | $-18 | $-144 |
| Total Liabilities And Equity | $9,492 | $11,312 | $1 | $0 | $1,445 |